News

The NHS will offer a once-daily triple therapy for cystic fibrosis to hundreds more patients, including those with rare ...
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...
Hundreds of people with cystic fibrosis are to be offered a once-a-day pill which has been hailed as “life changing” by ...
It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...
NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis ...
NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...
Licensed for use in the UK in March, Alyftrek will now be immediately funded by the NHS in England. This rapid timeline demonstrates NICE's commitment to getting breakthrough treatments to patients ...
Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently available drug Kaftrio.
Cystic fibrosis (CF) is a genetic disorder that causes thick, sticky mucus to build up in the lungs, digestive system and other organs ...
Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue ...
Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.